East Windsor, NJ—Sabinsa’s Curcumin C3 Complex with BioPerine was used as adjuvant therapy for COVID-19 in a double-blind, randomized, controlled clinical trial conducted on COVID-19 patients in India, according to a press release. The trial involved a total of 140 patients with mild, moderate, and severe symptoms of COVID-19. Patients...

Sioux Falls, SD—A new paper published in the American Journal of Clinical Nutrition showed that a low Omega-3 Index (O3I) is just as powerful a predictor of early death as smoking. The finding comes from data from the Framingham study, one of the longest running studies in the world, which...

Morristown, NJ, and Mumbai, India—OmniActive Health Technologies has presented multiple studies at the American Society of Nutrition conference, according to a press release from the company. The studies the company presented have all been published in Current Developments in Nutrition. Summaries of these studies below: OmniActive conducted a pharmacokinetic study...

Denver, CO—A team from Validcare met with members of FDA’s Cannabis Product Council in March to share initial findings from a human safety study of hemp-derived CBD products, according to a press release. The industry-sponsored study was commissioned and designed in response to FDA’s requests for science-based data, so that...

Oslo, Norway—A new study supported by Kappa Bioscience has confirmed that vitamin K status is lower in hospitalized patients with COVID-19, compared to a healthy population control group. The research also showed low vitamin K status to be predictive of higher mortality. The research was sparked by initial promising data...

Irvine, CA—BGG World (BGG) announced the publication of a clinical trial related to MyrtiPro (BGG’s standardized Bilberry extract containing 36% anthocyanins by HPLC) for eye health. The double-blind, placebo-controlled, randomized parallel-group study involved 32 healthy Japanese adults who were administered either one  120-mg MyrtiPro capsule containing 43.2mg anthocyanins per day or a placebo, according to a press release. The primary outcome:...

Oslo, Norway and East Brunswick, NJ—NattoPharma announced that a new 1.5-year placebo-controlled, randomized, open-label intervention clinical trial using MenaQ7 Vitamin K2 as MK-7 has been registered on ClinicalTrials.gov, and is scheduled to start in September 2021. The trial, titled The Effect of Vitamin K2 Supplementation on Arterial Stiffness and Cardiovascular...

Bangalore, India—There is a growing optimism around the food and nutrition industry globally. That's the word from a global industry survey conducted by nutraceuticals i2c (idea-to-commercialization) platform Nutrify Today, in collaboration with the nutraceuticals brand marketing firm Baker Dillon Group. Nutraceutical industry leaders from the U.S., Israel, Switzerland, Singapore, India, Hong...

Secaucus, NJ—Lycored’s Lumenato can help preserve the collagen network and help protect skin from damage, according to a pre-clinical study published in PLoS One 2021. Lumenato—a blend of natural tomato nutrients—was specifically shown to prevent the loss of type III collagen, which typically decreases in response to issues including inflammatory...

Hadley, MA—Delta-tocotrienol from annatto has been shown in a new clinical study to improve glycemic control, inflammation, and oxidative stress in patients diagnosed with type 2 diabetes mellitus, according to a press release from American River Nutrition. The randomized, double-blind, placebo-controlled trial was published in Phytotherapy Research. It was performed...